Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Progression-Free Survival in Metastatic Breast Cancer by Local Investigators vs Blinded Independent Central Review: A Systematic Review and Meta-Analysis.
Journal: JAMA oncology
Published: July 16, 2026
ASO Visual Abstract: Clinical Impact and Outcomes of Neoadjuvant Systemic Therapy for Invasive Lobular Carcinoma.
Journal: Annals of surgical oncology
Published: July 06, 2026
Practical approach to MRD testing in breast cancer: Q&A.
Journal: Clinical advances in hematology & oncology : H&O
Published: June 12, 2026
MRD testing across the continuum of care.
Journal: Clinical advances in hematology & oncology : H&O
Published: June 12, 2026
Molecular residual disease (MRD) testing: advancing clinical decision-making in breast cancer.
Journal: Clinical advances in hematology & oncology : H&O
Published: June 12, 2026
Clinical Impact and Outcomes of Neoadjuvant Systemic Therapy for Invasive Lobular Carcinoma.
Journal: Annals of surgical oncology
Published: March 10, 2026
Prevalence and Outcomes of HER2-Low Versus HER2-0 Status in Patients with Metastatic Breast Cancer.
Journal: Cancers
Published: December 09, 2025
Prevalence of HER2-low status and outcomes in early-stage HER2-negative breast cancer.
Journal: NPJ breast cancer
Published: July 14, 2025
Impact of concurrent lobular carcinoma in situ on recurrence outcomes in patients with classic and pleomorphic invasive lobular carcinoma of the breast.
Journal: Breast cancer research and treatment
Published: June 23, 2025
Immediate and ipsilateral recurrence rates and treatment recommendations for patients with pleomorphic and florid lobular carcinoma in situ.
Journal: Breast cancer research and treatment
Published: May 13, 2025
Incidence and risk factors for pneumonitis due to trastuzumab Deruxtecan in metastatic breast cancer: a retrospective cohort study.
Journal: Breast cancer research : BCR
Published: May 07, 2025
Last Updated: 09/26/2026